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1. Introduction  
Stem cells (SCs) are a rare population of cells characterized by the ability to self-renew in 
order to preserve the SC pool and to differentiate in different lineage to produce progeny 
needed for the physiological functions of tissues and organs. SC can be classified as 
embryonic SC (ESC) and adult  or somatic SC (ASC): ESC have been isolated from the inner 
cell mass of the blastocyst  and are pluripotent cells, that is cells able to differentiate into all 
the cell types required to form an entire organism (Smith, 2001); ASC are tissue-resident SC 
that, based on their differentiation potency, can be classified as multipotent, oligopotent or 
even unipotent. It is still controversial whether every mammalian tissue and organ 
possesses an ASC, but many tissue-specific ASC have been successfully identified and 
isolated e.g., hematopoietic SCs (HSCs), mammary SCs, muscle SCs (satellite cells), 
intestinal SCs, and mesenchymal SCs. All these tissues need to constantly replace damaged 
or dead cells throughout the life of the animal. This process of continual cell replacement 
critical for the maintenance of adult tissues,  is called tissue homeostasis, and is maintained 
through the presence of ASC (Fig. 1). The homeostatic replacement of cells varies 
substantially among different tissues. The epithelium of the intestine is one of the most 
rapidly self-renewing tissue in adult mammals and it completely self-renews in around 5 
days (van der Flier & Clevers, 2009). By contrast, interfollicular epidermis takes 4 weeks to 
renew (Blanpain & Fuchs, 2009), whereas the lung epithelium can take as long as 6 months 
to be replaced (Rawlins & Hogan, 2006). Moreover, apart from the maintenance of tissue 
homeostasis,  ASC are devoted to the regeneration and repair of highly specialized tissues. 
Regeneration refers to the proliferation of cells to replace lost structures, such as the growth 
of an amputated limb in amphibians. In mammals, whole organs and complex tissues rarely 
regenerate after injury, but tissues with high proliferative capacity, such as the 
hematopoietic system and the epithelia of the skin and gastrointestinal tract, renew 
themselves continuously and can regenerate after injury, as long as the SC of these tissues 
are not destroyed (Fig. 1). Repair most often consist of a combination of regeneration and 
scar formation by the deposition of collagen which relative contribution depends on the 
ability of the tissue to regenerate and the extent of the injury. For instance, in superficial 
injury of the skin, wound can heal through the regeneration of the surface epithelium. 
However, scar formation is the predominant healing process that occurs when the 
extracellular matrix framework is damaged by severe injury (Fig. 1). This last mechanism 
results in restoration of tissue continuity but with or without function (Gurtner et al., 2008). 
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Fig. 1. Normal homeostasis and healing responses. In normal homeostasis a balance 
between proliferation and cell death maintains the tissue structure and function. Healing 
after acute injury can occur by regeneration, that restores normal tissue structure, or repair 
with deposition of collagen fibers and scar formation.  
2. SCs and their niches  
Self-renewal and differentiation of ASC are supported by two types of cell division known 
as symmetric and asymmetric (Morrison & Kimble, 2006). With  symmetric division both the 
daughter cells acquire similar fates, while the asymmetric division, a fundamental and 
nearly universal mechanism for the generation of cellular diversity and pattern, gives rise to 
daughter cells with dissimilar fates. Divergent fates in daughter cells may be recognized by 
various characteristics: (i) morphological, such as cell size and shape; (ii) molecular, such as 
the segregation of proteins into only one daughter cell; or (iii) behavioural, such as the 
subsequent descendant types produced by either of the daughter cells. One mechanism for 
fate determination of daughter cells following symmetric and asymmetric cell divisions is 
the partitioning of fate-determining molecules during mitosis of the mother cell (Tajbakhsh 
et al., 2009). The idea that specific molecules can be partitioned unequally to daughter cells 
and behave as fate determinants had been hypothesized over a century earlier, following 
observations of cell divisions in simple organisms. When an intrinsic mechanism is used, 
cells establish an axis of polarity, orient the mitotic spindle along this axis and localize cell 
fate determinants to one side of the cell. During cytokinesis, determinants are then 
segregated into one of the two daughter cells where they direct cell fate (Betschinger & 
Knoblich, 2004). However, this hypothesis was only experimentally validated a little under 
two decades ago, with the identification of the first asymmetrically segregated cell fate 
determinant – Numb (Rhyu et al., 1994).  
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Alternatively, the SC depends on the contact with the surrounding microenvironment (the 
SC “niche”) for maintaining the potential to self-renew (Li & Xie, 2005). By orienting its 
mitotic spindle perpendicularly to the niche surface, the SC will placed the two daughters in 
distinct cellular environments either inside or outside the SC niche, leading to asymmetric 
fate choice. However, when SC divides parallel to the niche it may also generate two 
identical SC in order to increase SC number or to compensate for occasional SC loss 
(Yamashita et al, 2010). The concept of the “niche” was proposed first by Schofield 
(Schofield, 1978) who hypothesized that proliferative, hematopoietic cells derived from the 
spleen displayed decreased proliferative potential when compared to HSC obtained from 
the bone marrow because they were no longer in association with a complement of cells, the 
“niche”, which supports long term SC activity. This concept subsequently has proven 
relevant to many different SC systems, and the definition of the niche has been expanded 
further to include functional regulation of SC by both cellular and acellular (extracellular 
matrix) component of the niche. Thus the niche comprise all the microenvironment 
surrounding SCs, which provides diverse external cues to instruct SCs activities, preserve 
their proliferative potential and block maturation (Jones & Wagers, 2008).  
3. Signaling pathways regulating SC function  
Despite morphological and functional differences among different ASC, common signaling 
pathways appear to control SC self-renewal, activation, and differentiation, including Notch 
and Wingless-type (Wnt). 
3.1 Notch signaling pathway 
The Notch signaling pathway was discovered in flies more than 90 years ago (Morgan, 
1917), and it is among the most well-conserved signaling pathways in animals. It arose with 
the evolution of multicellular organisms and the concomitant need for juxtacrine cell-to-cell 
communication to coordinate development. In mammals, four Notch transmembrane 
receptors (Notch1-4) have been described. Notch ligands are also transmembrane proteins 
comprising two different subtypes (Delta, Jagged), each containing several members 
(Jagged1-2, Delta-like1, 3, and 4) (Kopan & Ilagan, 2009). In Notch signaling, a 'signal-
sending cell' presents the Notch ligand to the 'signal-receiving cell', which expresses the 
Notch receptor. Triggering of Notch receptor by ligand binding promotes two proteolytic 
cleavage events at the Notch receptor (Fig. 2) (Kopan & Ilagan, 2009). The first cleavage is 
catalyzed by the ADAM-family of metalloproteases, whereas the second cleavage is 
mediated by γ-secretase, an enzyme complex that contains presenilin, nicastrin, PEN2 and 
APH1. The second cleavage releases the Notch intracellular domain (NICD), which is free to 
translocate to the nucleus where it engages CSL, converting it from a transcriptional 
repressor to an activator and activates transcription of genes containing CSL binding sites 
(Kopan & Ilagan, 2009). In the absence of a Notch signal, CSL represses transcription of 
Notch target genes by interacting with the basal transcription machinery and recruiting 
ubiquitous corepressor proteins to form multiprotein transcriptional repressor complexes 
(Lai, 2002). In the presence of a Notch signal, NICD binding to CSL displaces corepressors 
from CSL. The best characterized Notch target genes belong to the hairy enhancer of split 
(Hes) complex and consist of the b-HLH transcription factors Hes (1-7) and Hey (1-3) (Bray 
& Bernard, 2010).  
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Fig. 2. Model of Notch signaling pathway. See the text for detail. 
3.2 Wnt signaling pathway 
The Wnt signaling pathway is  a highly conserved developmental pathway, and orchestrates 
development and morphogenesis in many different tissues. Wnt proteins are secreted 
proteins, that bind to receptors of the Frizzled family (FZD) (Wodarz & Nusse, 1998), of 
which 10 members were found, and several coreceptors such as lipoprotein receptor-related 
protein (LRP)-5/6, (Pinson et al., 2000) Ryk, or Ror2 (Logan & Nusse, 2004). Wnt signals can 
be transduced to the canonical, or Wnt/β-catenin, pathway and to the noncanonical, or β-
catenin independent, pathway.  
3.2.1 Canonical Wnt signaling pathway 
The canonical Wnt pathway involves the multifunctional protein ǃ-catenin (MacDonald et 
al., 2009). In the absence of Wnt, ǃ-catenin is targeted to a multimeric destruction complex 
with adenomatous polyposis coli (APC) and Axin and is phosphorylated by casein kinase 
1α, followed by phosphorylation by glycogen synthase kinase (GSK)3ǃ (Fig.34) (Ikeda et al., 
1998). This phosphorylation targets ǃ-catenin for ubiquitination and degradation by the 
proteasome. The binding of Wnt ligands to the FZD receptors results in the disassembly of 
the destruction complex and the stabilization of ǃ-catenin. This process also involves the 
protein dishevelled (DVL). Cytoplasmic ǃ-catenin accumulates and is eventually imported 
into the nucleus, where it serves as a transcriptional coactivator of transcription factors of 
the TCF/LEF family (Arce et al., 2006). TCF/LEF target genes are then involved in 
regulating cell proliferation, SC maintenance, or differentiation. 
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3.2.2 Noncanonical Wnt signaling pathway 
Different noncanonical Wnt signals are transduced through FZD receptors and coreceptors. 
Depending on the major intracellular mediators used, those are called the Wnt/JNK 
(Veeman et al., 2003) or Wnt/calcium pathway (Fig. 3). The core element of the Wnt/JNK 
pathway (or planar cell polarity –PCP- pathway) includes the activation of small GTPases of 
the rho family, such as rac, cdc42, and rhoA. The GTPases can activate more downstream 
mediators like JNK or rho kinase (ROK). In this branch, Dvl is also recruited by a FZD 
receptor and promotes the asymmetrical localization of the PCP core proteins within the cell 
(Montcouquiol, et al. 2006). The asymmetrical subcellular localization of these elements in 
an epithelial sheet directs cytoskeletal reorganization. The same mechanism is used in 
mesenchymal cells to direct cell movement and migration during gastrulation (convergent 
and extension movements) (Roszko, et al., 2009).  
 
Fig. 3. Model of canonical and noncanonical Wnt signaling pathway. See the text for detail. 
The existence of the Wnt/calcium pathway was hypothesized because injection of RNA 
coding for certain Wnts or FZD into early zebrafish embryos triggered intracellular calcium 
release (Slusarski et al., 1997) and loss of Wnt-11 or Wnt-5A function resulted in reduced 
intracellular calcium signaling (Eisenberg & Eisenberg, 1999; Westfall et al., 2003). This 
finding was subsequently expanded by the observation that the Wnt-induced release of 
intracellular calcium is sufficient to activate different intracellular calcium-sensitive 
enzymes such as protein kinase C, PKC (Sheldahl et al., 1999), calcium–calmodulin-
dependent kinase II, CamKII (Kuhl et al., 2000) and the calcium-sensitive phosphatase 
calcineurin (Saneyoshi et al., 2002). Through calcineurin the Wnt/calcium pathway connects 
to NFAT (nuclear factor of activated T cells) transcription factor and gene expression. 
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Presently, a series of recent findings clearly indicate that different Wnt signaling pathways 
are simultaneously active within the same cell type, supporting the idea that Wnt pathways 
are highly connected to form a Wnt signaling network. This network seems to be activated 
by either one or more ligands acting on a certain cell type (Kestler & Kuhl, 2008). 
3.3 Wnt signaling inhibitors 
Secreted frizzled-related proteins (SFRP1, 2, 3, 4, 5), WIF1, DKK1, -2, -3, and -4 are secreted-
type Wnt signaling inhibitors. WIFs and SFRPs can directly bind to Wnt proteins in the 
extracellular space, thereby affecting receptor occupancy and, ultimately, the cellular 
response (Bovolenta et al., 2008). DKK1 is among the best-characterized inhibitors of the 
canonical Wnt pathway. DKK1 itself is a target gene of Wnt/ǃ-catenin signaling, thereby 
establishing a negative-feedback loop (Niida et al., 2004). There are two possible 
mechanisms by which DKK1 inhibits ǃ-catenin signaling. One possible mechanism is that 
DKK1 prevents the formation of Wnt–FZD–LRP6 complexes on the cell surface by binding 
to LRP6 (Seto et al., 2006). Another possibility, which is related to the internalization of 
LRP6, is that DKK1 binds to another class of receptor, Kremen (Krm). In this model, the 
binding of DKK1 to LRP6 and Krm results in the formation of a ternary structure and 
induces rapid endocytosis and the removal of LRP6 from the plasma membrane, and 
thereby attenuates ǃ-catenin signaling (Mao et al., 2002).  
4. Hematopoietic SCs 
In adult mammals, HSCs form a rare population of multipotent SCs that reside primarily in 
the bone marrow (BM). They have the capability to both self-renew and constantly give rise 
to lineage-specific progenitor cells and effector blood cells that perform the physiological 
functions of the hematopoietic system. Blood cells can be classified into various cell types, 
from the myeloid (monocytes and macrophages, neutrophils, basophils, eosinophils, 
erythrocytes, megakaryocytes/platelets, dendritic cells), and lymphoid lineages (T-cells, B-
cells, NK-cells) (Liu et al., 2010).  
HSCs are functionally defined by their capacity to reconstitute the hematopoietic system of 
immunodeficient animals such as NOD/SCID mice or contribute to functional 
reconstitution in human transplant settings. HSCs can be identified and isolated by a 
combination of presence and absence of cell surface markers. The most commonly used 
combination is characterized by the positive expression of the tyrosine kinase receptor c-Kit 
(CD117) and the membrane glycoprotein Sca-1 (Okada et al., 1992), together with the lack of 
markers of terminal differentiation (Ter119, Gr-1, Mac-1, B220, CD4 and CD8), collectively 
known as Lineage markers. The resulting c-Kit+ Sca-1+ Lin- population, is commonly 
referred to as KSL cells. More recently, an alternative method was described, using a 
signature of SLAM (Signaling lymphocyte activation molecule) family of cell surface 
molecules, CD150+ CD244- CD48- (Kiel et al, 2005). This is the first family of receptors 
whose combinatorial expression precisely distinguishes HSCs from hematopoietic 
progenitor cells (HPC). 
The BM microenvironment –also called niche- plays an important role in the regulation of 
self-renewal and differentiation of HSCs. It is composed of different types of cells and 
structures surrounding the bone, which regulates the fate of hematopoietic cells through 
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direct or indirect means, facilitating a stable generation of all the blood cells needed in a 
steady state situation. But the niche also adapts in times of hematopoietic stress. A failure to 
maintain a strict regulation of the hematopoietic cells can lead to a variety of malignancies 
such as leukemia, the most common form of cancer in humans (Renstrom et al., 2010). 
4.1 Notch pathway as a regulator of HSC behavior 
All Notch receptors and ligands are expressed on HSCs (Singh et al., 2000) and it is now 
well established that Notch signaling is essential for the production of HSCs during 
embryogenesis. However, its role in subsequent stages of mammalian HSC development is 
still controversial (Liu et al, 2010; Radtke et al., 2010). 
In adult hematopoiesis, activation of Notch signaling has been reported to promote HSCs 
self-renewal, proliferation and differentiation in vitro and in vivo, and in both mice and 
humans. Constitutive expression of NICD by HSCs, leading to the constitutive activation of 
the Notch pathway, enhances proliferation and consequently delays hematopoiesis. 
Conversely, it inhibits differentiation in response to various cytokines, mostly under 
myeloid promoting conditions (Carlesso et al, 1999). Several reports show that HSCs 
stimulated with soluble or membrane-bound Notch ligand Delta 1 (Karanu et al, 2001) or 
Jagged1 (Karanu et al. 2000) increase in expansion potential in vitro and in reconstitution 
capacity in vivo. Although these gain-of-function studies show an important role for Notch 
in expanding the HSC pool, they do not prove that Notch is essential for post-natal 
hematopoiesis. The controversy arises from several loss-of-function studies in mice that did 
not fully support the previous conclusions. In particular, inactivation of Notch receptors 
(Notch1, Notch2), ligands (Jagged1) or downstream effectors (CSL/RBPJ, Mastermind-like1) 
does not impair HSC function (Cerdan & Bhatia, 2010). Additional studies failed to identify 
a protective role for Notch when HSCs were exposed to oxidative stress. Taken together, 
these results show that Notch signaling is not a major regulator of adult HSC maintenance 
in vivo. Downstream of HSCs, Notch signaling plays a critical role in cell fate decision of a 
variety of oligopotent progenitor cells in the hematopoietic system, such as in T-cell 
development. Inactivation of Notch signaling in HPCs results in early blockade of T-cell 
lymphopoiesis, due to a failure in commitment to the T-cell lineage. Transgenic mice with a 
conditional deletion of Notch1 do not develop T-cells but develop ectopic B-cells in the 
thymus, while immunodeficient mice expressing a constitutively active form of Notch1 
develop ectopic T-cells in the bone marrow (BM) but no B-cell (Tanigaki & Honjo, 2007). 
Additionally, Notch1 signaling is necessary at various stages of T-cell development, such as 
progression through thymocyte maturation, regulation of T-cell Receptor ǃ (TCR-ǃ) gene 
rearrangement, regulation of lineage decisions between ǂǃ and Ǆǅ lineages (Tanigaki & 
Honjo, 2007).  
4.2 Role of Notch in T-cell leukemia 
The pathological role for a deregulated Notch signaling was first described in a rare human 
T-cell acute lymphoblastic leukaemia/lymphoma (T-ALL), in which a t(7;9) chromosomal 
translocation results in the generation of a constitutively active, but truncated form of the 
Notch1 receptor named TAN1 (Translocation Associated Notch homolog) (Ellisen et al., 
1991). Evidence that constitutively active Notch1 is responsible for disease development was 
provided by murine BM reconstitution experiments. Irradiated mice transplanted with BM 
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progenitors expressing activated forms of Notch1 developed clonal hematopoietic tumors 
characterized as T-ALL. Experiments performed using other truncated Notch isoforms, 
including Notch2 and Notch3, showed similar results. However, mice having a defect in T-
cell development failed to produce tumors. These results reveal that Notch1 has a special 
oncotropism for T-cell progenitors (Radtke et al., 2010). These findings became extremely 
relevant when a study of a large number of T-ALL patients revealed in more than 50% of 
them the presence of at least one gain-of-function mutation in the Notch1 receptor, 
emphasizing the oncogenic role of Notch (Weng et al., 2004). Notch1 mutations found in T-
ALL affect critical domains responsible for preventing the spontaneous activation of the 
receptor in the absence of ligand or for terminating Notch1 signaling in the nucleus.  
Studies of the genes and pathways controlled by Notch in T-ALL identified Notch1 as a 
central regulator, promoting leukemia cell growth by multiple direct and indirect 
mechanisms (Fig. 4) (Paganin & Ferrando, 2011). Analysis of Notch1 expression in T-ALL 
showed that it acts as a direct transcriptional activator of multiple genes. Notch1 also 
promotes the expression of the MYC oncogene, which in turn further enhances its direct 
effect on anabolic genes and facilitates cell growth. Indeed, many of the anabolic genes 
directly controlled by Notch1 are also direct targets of MYC, creating a feed-forward-loop 
transcriptional network that promotes leukemic cell growth (Palomero et al., 2006). 
Additionally, Notch1 facilitates the activation of the PI3K-AKT-mTOR signaling pathway, a 
critical regulator of cell growth and metabolism, via transcriptional downregulation of the 
PTEN tumor suppressor gene by Hes1, a transcriptional repressor directly downstream of 
Notch1 signaling (Palomero et al., 2007). The mTOR signaling was suppressed in T-ALL 
cells upon inhibition of Notch signaling, illustrating the importance of this indirect 
mechanism of regulation. The transcriptional program activated by oncogenic Notch1 also 
has a direct effect on cell cycle progression, promoting of G1/S cell cycle progression in T-
ALL. This effect is mediated in part by transcriptional upregulation of CCND3, CDK4 and 
CDK6. Moreover, Notch1 induces the transcription of the S phase kinase-associated protein 
2 (SKP2), which mediate the proteasomal degradation of CDKN1B (p27/Kip1) and 
CDKN1A (p21/Cip1), promoting premature entry of the cells into S phase (Sarmento et al, 
2005). Notch1 can also modulate the survival of T-ALL cells by interacting with NF-κB, 
upregulating its activity by increasing expression of IκB kinase and upregulating both the 
expression and the nuclear localization of NF-κB. Inhibition of NF-κB in T-ALL can 
efficiently restrict tumor growth both in vitro and in vivo (Vilimas et al., 2007).  
In addition, Notch1 modulates the NFAT cascade through the activation of calcineurin, 
which is a calcium-activated phosphatase that is important for the activation and 
translocation of NFAT factors to the nucleus. Calcineurin inhibition resulted in T-ALL cell 
death, as well as tumor regression and prolonged survival of leukemic mice (Medyouf et al., 
2007). Finally, Notch1 regulates the activity of p53, lowering its expression through 
repression of the ARF-mdm2-p53 surveillance network. Attenuation of Notch signaling led 
to increase p53 expression and to tumor regression by inducing apoptosis (Beverly et al., 
2005). A strong body of evidence supports a central role of Notch1 in promoting cell 
metabolism, growth and proliferation, as well as in enhancing the activity of signaling 
pathways that reinforce these functions and also promote cell survival. These results suggest 
that blocking Notch1 signaling may reduce the self-renewal capacity of T-ALL cells and/or 
selectively affect the leukemia initiating cell population. 
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Only few Notch mutations have been reported in myelogenous leukemias, but it is unclear 
whether Notch aberrant expression is responsible for the disease. 
 
Fig. 4. Genes and pathways controlled by Notch in T-ALL 
4.3 Wnt pathway and HSC 
In hematopoiesis, Wnt pathway activity is required in the BM niche to regulate HSC 
proliferation and preserve self-renewal capacity (Malhotra & Kincade, 2009). Even though 
the role of canonical signaling on the regulation of adult hematopoiesis has been studied 
in great detail, controversy remains, possibly explained by differences in strength and 
duration of Wnt signaling or redundancy with other pathways. A role for Wnt signaling 
in hematopoiesis is supported by observations that Wnt ligands enhance proliferation of 
HSCs ex vivo (Van Den Berg et al, 1998) and that Wnt antagonists inhibit HSC 
proliferation and reconstitution. In particular, only short-term repopulation was reported 
using HSCs from normal mice cultured with Wnt3A (Reya et al., 2003; Willert et al., 2003). 
Subsequent studies reported that noncanonical Wnt5a inhibited canonical Wnt3a-
mediated signaling to promote the maintenance of quiescent, functionally transplantable 
HSCs. In addition constitutively active nuclear ǃ-catenin signaling reduces HSC 
quiescence and blocks HSC differentiation (Kirstetter et al., 2006). On the other hand, 
osteoblast-specific expression of Dkk1 results in increased HSC cycling and reduced 
regenerative capacity (Fleming et al, 2008). These findings suggest that Wnt pathway 
activation in the niche limits HSC proliferation and preserves self-renewal. These 
observations suggest that fine-tuning of Wnt/ǃ-catenin activity in the microenvironment 
is crucial for maintaining SC quiescence. 
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The canonical Wnt pathway has also been shown to be necessary for appropriate HSC 
development (Zhao et al., 2008). In this model, Ctnnb1-/- bone marrow cells are deficient in 
long-term HSC maintenance and compete poorly against wild-type cells. However, 
experiments in adult HSC revealed that Ctnnb1 is dispensable for HSC maintenance in fully 
developed HSC (Koch et al., 2008). This indicates differential requirements for self-renewal 
pathways in development versus maintenance of HSC. 
In the context of development, genetic studies have demonstrated the requirement for 
canonical signaling in the formation of mesoderm (Kelly et al., 2004; Liu et al., 1999). Recent 
advances have provided insights into the uniqueness of the biological functions of canonical 
and noncanonical pathways. It has been found that non-canonical and canonical Wnts 
affected different target populations and stages of hematopoietic development 
(Vijayaragavan et al., 2009). Consistent with its previously defined role in human adult cells 
(Van Den Berg et al., 1998), canonical signaling increased proliferation of blood committed 
progenitors when administered during the proper window of time during EB development. 
However, a short pulse of non-canonical signaling was necessary and sufficient to control 
exit of hESCs from the pluripotent state and subsequent entry into the 
mesendoderm/mesoderm lineages (Vijayaragavan et al., 2009). Taken together, these 
findings  provide the first evidence of a unique role for non-canonical signaling in early 
specification of hematopoiesis from hESCs, whereas canonical signaling affects the 
proliferation of cells already fated to blood. These studies provide a valuable model system 
for examining the possibility of chronological activation and interaction between non-
canonical and canonical signaling in the cellular progression from mesoderm to blood. The 
controversial  function of canonical signaling on the reconstituting capacity of adult HSCs, 
combined with these present findings in hESCs, underscores the importance of fine tuning 
the strength and duration of Wnt signaling towards therapeutically exploiting the balance 
between self-renewal and lineage commitment of HSCs. 
However, there are conflicting reports on the requirement for Wnt/ǃ-catenin signaling in 
basal hematopoiesis: conditional disruption of ǃ-catenin in adult HSCs does not affect their 
ability to self-renew and reconstitute hematopoietic lineages (Huang et al, 2009). In addition, 
although overexpression of stabilized ǃ-catenin increases immunophenotypic HSCs, this is 
associated with a loss of repopulating activity and hematopoietic failure in vivo (Kirstetter et 
al., 2006), findings that appear incompatible with a positive role for ǃ-catenin in 
hematopoiesis. A general conclusion from these apparently conflicting reports is that the 
role of Wnt signaling in hematopoiesis is complex and context dependent (Staal & Sen,. 
2008). However, although the ǃ-catenin loss-of-function studies suggest that canonical Wnt 
signaling is not essential for basal hematopoiesis in adults, they do not rule out a possible 
role for the Wnt/ǃ-catenin pathway under nonbasal conditions and are still compatible with 
gain-of-function experiments in which the pathway is activated. 
4.4 Wnt signaling and malignant HSC 
Stem cell quiescence is closely associated with protection from myelotoxic insults (Cheshier 
et al, 1999). Similar to the role of tissue SCs in normal tissues, several cancers are also 
propagated by small populations of quiescent cancer stem cells (CSCs) that are resistant to 
both conventional chemotherapy and targeted therapies, and are retained and contribute to 
relapse following discontinuation of therapy (Dick, 2008).  
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When Ctnnb1 was deleted contemporaneously with activation of BCR-ABL using retroviral 
infection and transformation of HSC, chronic myeloid leukemia stem cell (CML-LSC) failed 
to engraft in secondary recipient mice (Hu Y et al., 2009). These experiments clearly indicate 
a pivotal role of Wnt signaling in CML-LSC development. More recently, Ctnnb1 has been 
investigated in the maintenance of already engrafted CML-LSC. In this clinically relevant 
setting, pharmacologic or genetic inactivation of Ctnnb1 after onset of the myeloproliferative 
disease acted synergistically with imatinib, reduced LSC numbers, and improved survival in 
a BM transplant model (Abrahamsson  et al., 2009). Thus, despite its dispensability for adult 
HSC, CML-LSCs seem to retain dependency on canonical Ctnnb1 to maintain self-renewal 
capacity. In human disease, Ctnnb1 activation via the canonical Wnt pathway has been 
shown to occur in CML-blast crisis LSCs. Aberrant splicing of GSK3 appears to contribute to 
this hyperactivation in blast crisis samples (Abrahamsson  et al., 2009). Thus, there is 
growing evidence that canonical Wnt signaling is an attractive target pathway in the 
treatment of CML-LSC. Moreover, cell extrinsic inhibition of Wnt signaling through ectopic 
DKK1 expression impairs leukemia cell proliferation in vitro (Zhu  et al.,  2009). 
5. Intestinal SCs 
Homeostasis of the intestinal epithelium is maintained by an intestinal SC (ISC) 
compartment that resides at the bottom of the crypt, safely far from the shear stresses and 
potentially toxic agents. These ISC are at the top of a cellular hierarchy and are crucial for 
the renewal of the differentiated progeny within the intestinal layer (Medema & Vermeulen, 
2011). Indeed, as they migrate out of their niche, they cease to proliferate and initiate 
differentiation into the different cell lineages of the mature villi: absorptive enterocytes, 
mucin-secreting-goblet cells, peptide hormone-secreting neuroendocrine cells, and 
microbicide-secreting Paneth cells. Until relatively recently,  ISCs were a rather elusive 
entity at the bottom of the intestinal crypt, and the discovery of ISC markers has only partly 
detailed the organization of the intestinal crypt and villi. Briefly, the marker LGR5 identifies 
crypt base columnar cells (CBCC) located in between the Paneth cells at the crypt bottom 
(Barker et al., 2007), whereas the markers BMI1 and TERT identify the +4 position in the 
crypt, just above the Paneth cells (Montgomery et al., 2011; Sangiorgi & Capecchi, 2008). 
Knock-in constructs that allow expression of GFP and Cre from the Lgr5 locus show that 
LGR5 expression is confined to CBCCs, and that these cells give rise to the variety of 
epithelial cells present in crypts, proving that CBCCs function as ISCs as well (Barker et al., 
2007, Sato et al., 2009). The existence of these different types of ISC remains a matter of 
debate and notably, remains to be determined whether and how BMI1+ +4 cells ISCs and 
LGR5+ ISCs relate to each other. Interestingly, recent data indicate that TERT-expressing 
ISCs can generate LGR5+ISCs (Montgomery et al., 2011) suggesting that these different ISC 
types may act in a hierarchical fashion. Regardless of this dispute about ISC identity, there is 
a consensus that ISCs reside in a niche that provides the cells with essentials signals such as 
Wnt, Notch and Hedgehog. Under normal circumstances, the Paneth cell signals dictate the 
size of  the SC pool to maintain the total number of SCs within the niche constant. SCs may 
divide asymmetrically, so that one SC remains within the niche, resulting in self-renewal, 
whilst the other daughter cell gives rise to progenitor cells that can migrate up the crypt and 
become more differentiated as they reach the top.  Alternatively, two recent studies (Lopez-
Garcia et al., 2010; Snippert et al., 2010) support that SCs may divide symmetrically either 
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forming two daughter SCs (leading to expansion) or two daughter non-stem progenitor cells 
(leading to extinction). Several pathways play a role in maintaining and regulating stem 
ISCs, including Wnt and Notch. 
5.1 Notch signaling in intestinal epithelium 
In the intestine, Notch activity determines lineage decisions between enterocyte and 
secretory cell differentiation. Several components of the Notch pathway are expressed in 
adult intestinal crypt cells, suggesting a role for Notch signaling in gene expression 
programs in immature proliferating compartment cells (Sander & Powell, 2004; Schroder 
& Gossler, 2002). The first evidence that Notch signaling plays a role in cell-type 
specification in the intestine was reported  in Hes1 knockout mice (Jensen et al., 2000). The 
deletion of the Hes1 gene resulted in the generation of excessive numbers of goblet cells, 
enteroendocrine cells, and Paneth cells. Subsequently, it was shown that Math1 (mouse 
atonal homolog1), one of the genes repressed by Hes1, is required for the differentiation 
into the three secretory lineages, because the intestinal epithelium of Math1-mutant mice 
is populated only by absorptive cells (Yang et al., 2001). These data suggest that the choice 
between the absorptive or secretory fate might be the first decision made by each 
progenitor cells, and that Hes1 and Math1 activated by Notch signal play opposite roles in 
this decision making. Recently, using the villin promoter to drive the expression of a 
constitutively active form of mouse Notch1 receptor, it was noticed an expansion of 
proliferating intestinal progenitor cells (Fre et al., 2005). Moreover, Notch activation 
inhibited the differentiation of secretory cells in the mouse intestine, as there was a 
complete depletion of goblet cells, a marked reduction in enteroendocrine cells, and a low 
expression of early marker for Paneth cells. These results clearly suggest that Notch 
signaling is required for maintaining crypt cells in a proliferative state, at least in part, 
through its negative regulation of Math1. Conversely, conditional removal of the Notch 
pathway transcription factor CSL/RBP-J increases the proportion of goblet cells in the 
murine intestine, and a similar phenotype was observed using a γ-secretase inhibitor (van 
Es et al., 2005). These results suggest that Notch pathway is not only a gatekeeper for 
proliferating crypt progenitor cells, but is also involved in controlling the balance between 
secretory and absorptive cell types. Data suggest that the ISC microenvironment delivers 
Notch-activating signals to maintain stemness, which is consistent with the observation 
that Paneth cells express Notch ligands (Sato et al., 2011). In particular, recent papers 
identified Dll1 and Dll4 as the physiologically relevant Notch1 and Notch2 ligands within 
the small intestine of the mouse. These ligands cooperate and exhibit a partial functional 
redundancy to maintain the crypt progenitor compartment (Pellegrinet et al., 2011). 
However, Notch seems to have dual functions in the crypt, as it acts together with Wnt to 
affect significantly crypt homeostasis (Fre et al., 2005; van Es et al., 2005).  
5.2 Canonical Wnt signaling in intestinal epithelium 
The Wnt pathway proteins regulate cellular fate along the crypt-villus axis in normal gut 
epithelium and have been implicated in ISC self-renewal. The nuclear accumulation of β-
catenin is preferentially observed in cells located at the base of crypts and decreases as cells 
move toward the top of the crypts (van der Wetering et al., 2002). Wnt target genes EphB2 
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and EphB3 control crypt cellular segregation (Batlle et al., 2002), Sox9 regulates Paneth cell 
differentiation  (Mori-Akiyama et al., 2007), and Lgr5 (Barker et al., 2007). TCF4 null mice 
died shortly after birth and showed an embryonic epithelium made entirely of differentiated 
cells without proliferative compartments in the crypts (Korinek et al., 1998) suggesting that 
TCF4 maintains the proliferation of SCs in the murine small intestine. Notably, deletion of 
the Wnt/TCF4 target gene c-Myc led to a loss of intestinal crypts in a murine model 
(Muncan et al., 2006). The importance of the Wnt signaling pathway in maintaining the 
architecture and homeostasis of the adult intestinal epithelium was also shown  in a murine 
model through adenoviral expression of Dkk1. This induced Wnt inhibition in fully adult 
mice, resulted in inhibition of proliferation in the small intestine and colon, with progressive 
loss of crypts, villi and glandular structure (Kuhnert et al., 2004). By contrast, when the Wnt 
pathway is overactivated by mutations in APC or β-catenin, many of the epithelial cells 
enter into the proliferative state and display a failure of the differentiation programs 
(Andreu et al., 2005; Sansom et al., 2004). According with these data, recent papers 
demonstrated that injection of R-spondin1 (R-Spo1), a potent activator of the Wnt signaling 
pathways, induced rapid onset of crypt cell proliferation displaying epithelial hyperplasia in 
the intestine of normal mice through β-catenin stabilization and subsequent transcriptional 
activation of target genes such as murine Axin2, Ascl2, and Lgr5 (Kim et al., 2005; 
Takashima et al., 2011). The effects of R-Spo1 administration determine protection against 
radiation-induced colitis by stimulating proliferation of  intestinal SCs and protect them 
against a damage after allogeneic bone-marrow transplantation, suppressing inflammatory 
cytokine cascades and donor T cell activation (Takashima et al., 2011). These, in vivo, data 
suggest that Wnt signaling is directly linked to the promotion of cellular proliferation and, 
more specifically, the regulation of progression through cell cycle. In this regard, previous 
papers pointed to the downregulation of p21cip1waf1, a cyclin-dependent kinase inhibitor 
(CKI), as an important mechanism that might mediate Wnt-dependent growth promotion. A 
microarray analysis showed that p21cip1waf1 was one of the genes whose expression was 
increased by inhibition of Wnt signaling in human colorectal cancer-derived LS174T cells 
(van der Wetering et al., 2002). Furthermore, the TCF4 target gene c-Myc has been shown to 
play a central role in Wnt-mediated repression of p21cip1waf1 expression at the transcriptional 
level through its direct binding to the p21cip1waf1 gene promoter (van der Wetering et al., 
2002). These data suggest that the repression of p21cip1waf1 by c-Myc might be the 
intracellular mechanism by which Wnt signaling regulates the G1/S transition and cell cycle 
progression. This signaling cascade has been shown to be functional in vivo, because 
abnormal features of proliferation/differentiation in the adult murine intestine, which occur 
with the single deletion of APC, are mostly rescued when c-Myc gene is simultaneously 
deleted (Sansom et al., 2007). Furthermore, this restoration of the morphologically normal 
phenotype in double mutant mice for APC and c-Myc is accompanied by restoration of p21 
expression within the crypts, suggesting the involvement of p21 in the Wnt-c-Myc pathway-
mediated growth control of progenitor cells. Indeed, raises the possibility that p21 is an 
intracellular molecular switch between proliferation and differentiation. Moreover, it has 
been shown that  conditional expression of p21cip1waf1 alone allow cells to differentiate  (van 
der Wetering et al., 2002) suggesting that the cell fate choice between proliferation and 
differentiation is regulated by modulation of the expression of p21cip1waf1 via the direct 
induction of c-Myc by Wnt signaling. 
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Fig. 5. The role for Notch and Wnt pathways in intestinal epithelial proliferation and 
differentiation. The ISC can give rise to four lineages of terminally differentiated cells: a is 
absorptive cells, b and c (Paneth, goblet and enteroendocrine cells) have secretory 
phenotypes. See the text for detail. 
In general, the data strongly support a model in which Notch directs proliferation when 
Wnt signal activity is high, and directs enterocyte differentiation when Wnt activity levels 
drop towards the top of the crypt. The multipotent progenitors require both Wnt and Notch 
signals to be activated for fulfilling continuous proliferation without differentiation. Once 
some cells in this Wnt and Notch-activated population escape from the Notch signal, they 
stop proliferating and acquire the Math1 function. These cells raise the terminally 
differentiation in secretory cells in areas where the Wnt signal is not active (Pinto et al.,  
2003), whereas they differentiate in Paneth cells if they remain at the bottom of the crypt 
where Wnt ligands are abundant. By contrast, if cells in this Wnt and Notch-active 
population lose the Wnt signal, for example, because of their positional changes along the 
vertical axis, they differentiate as absorptive cells (Fig. 5). 
5.3 SCs and the origin of intestinal cancer 
Despite stringent homeostatic maintenance in the intestine, the high number of patients 
with colorectal cancer (CRC) indicates that these regulatory mechanisms often fall short in 
protecting against malignant transformation. Both environmental and genetic risk factors 
have been defined for CRC, and deregulation of morphogenetic pathways plays a key part 
in cancer development. Notably, the vast majority of sporadic CRC cases carry Wnt 
pathway mutations, highlighting the importance of this pathway in CRC. The hit that 
induces transition from normal to polypoid tissue is accompanied by several changes in 
crypt appearance and behavior, cells show a more immature phenotype and a higher 
proliferative index which results in expansion of the pre-malignant clone. Although 
www.intechopen.com
 
Adult Stem Cells in Tissue Homeostasis and Disease  393 
mutation of APC or β-catenin is an early event in the transformation of colonic epithelial 
cells, studies have revealed that colon carcinomas do not contain nuclear β-catenin 
homogeneously (Fodde & Brabletz, 2007). This so-called β-catenin paradox indicate that 
Wnt signaling has a preponderant role only for a subset of tumour cells, cancer SCs (CSCs), 
which are endowed with tumorigenic capacity (Vermeulen et al., 2008). Indeed, the past 
decade has seen a shift in the way tumours are perceived, and the now widely accepted 
model is that tumours contain a small population of self-renewing CSCs, as well as a large 
compartment of more differentiated tumour cells (Vermeulen et al., 2008). Cellular hierarchy 
within CRC is maintained, at least in part, by microenvironmental factors regulating 
stemness and differentiation. In agreement, tumour cells located next to myofibroblast-rich 
regions, have a much higher incidence of nuclear-localized β-catenin, suggesting for 
microenvironment-modulated Wnt signaling (Fodde & Brabletz, 2007). A recent paper point 
to hepatocyte growth factor (HGF) as the myofibroblast-derived signal that, at least in part, 
orchestrates this intimate relationship and enhances Wnt activity in more differentiated 
tumour cells, thereby reinstalling CSCs features (dedifferentiation) (Vermeulen et al., 2010). 
Indeed, using a TCF/LEF reporter that directs the expression of enhanced green fluorescent 
protein, authors provided evidence that Wnt signaling activity is a marker for colon CSCs 
and is regulated by the microenvironment. Moreover, they show that differentiated cancer 
cells can be reprogrammed to express CSC markers and regain their tumorigenic capacity 
when stimulated with myofibroblast-derived factors (Vermeulen et al., 2010). Although, 
these data clearly ascertain a role for the Wnt pathway in CRC stemness, Notch inhibition 
with an antibody against the Notch ligand Dll4 results in human colon CSCs differentiation, 
reduction of CRC growth in a xenotransplantation model and chemosensitization (Hoey et 
al., 2009).  
6. Identification of Renal SCs 
The mammalian kidney shares with the majority of organs the ability to repopulate and at 
least partially repair structures that have sustained some degree of injury. Indeed, tubular 
integrity can be rescued after acute damage, and even severe glomerular disorders 
sometimes may undergo regression and remission, suggesting that glomerular injury is also 
reparable (Imai & Iwatani, 2007; Remuzzi, et al., 2006). However, the existence of renal SC 
(RSC) has been a matter of long debate. Recently, converging data definitively demonstrated 
the existence of a population of stem/progenitor cells in the parietal epithelium of the 
Bowman’s capsule of adult human kidney (Sagrinati, et al., 2006) (Fig.6). These SC coexpress 
both CD24, a surface molecule that has been used to identify different types of human SC, 
and CD133, a marker of several types of adult tissue SC, lack lineage-specific markers,  
express transcription factors that are characteristic of multipotent SC, and exhibit self-
renewal, high clonogenic efficiency and multidifferentiation potential. When injected 
intravenously in SCID mice that had acute kidney injury, RSC regenerated tubular 
structures from different portions of the nephron and also reduced the morphological and 
functional kidney damage (Sagrinati, et al., 2006).  
In addition, it was demonstrated that RSC are arranged in a precise sequence within 
Bowman’s capsule of adult human kidneys (Ronconi, et al., 2009) (Fig. 6).  
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Fig. 6. Localization of RPC in the glomerulus. RPC (green) are localized in the Bowman’s 
capsule epithelium. A transitional cell population (podocyte progenitors, green/yellow) 
displays features of either RPC or podocyte (yellow) and localize between the urinary pole 
and the vascular stalk. Cells that express only podocyte markers and the phenotypic 
features of differentiated podocytes (yellow) localize at the vascular stalk of the glomerulus. 
These findings obtained in human kidneys were confirmed in a parallel study performed in 
murine kidney by Appel (Appel, et al., 2009), who also demonstrated the existence of 
transitional cells with morphological and immunohistochemical features of both parietal 
epithelial cells and podocyte in proximity of the glomerular vascular stalk and that 
podocytes are recruited from parietal epithelial cells, which proliferate and differentiate 
from the urinary to the vascular stalk, then generating novel podocytes (Fig. 6). This occurs 
as the kidney grows, during childhood and adolescence, and may also take place following 
an injury which allows a slow, regulated generation of novel podocytes, such as 
uninephrectomy. Recently, a rare subpopulation of CD133+CD24+ cells has also been 
describe in renal tubules (Lindgren, et al., 2011). These cells are able to proliferate and 
differentiate after tubular injury. Accordingly, tubular epithelium regenerating on acute 
tubular necrosis displayed long stretches of CD133+CD24+ cells, further substantiating that 
the cells that are repairing tubular epithelium may simply represent the result of 
proliferation and differentiation of CD133+CD24+ tubular progenitors. 
6.1 Involvement of RSC in glomerular disorders and cancer 
It has been widely recognized that a disruption in the strictly regulated balance of SC self-
renewal and differentiation not only impairs regenerative mechanisms but can even 
generate disorders. In the glomerulus, the response to podocyte injury may cause aberrant 
epithelial cell proliferation, hypercellular lesions formation and Bowman’s space 
obliteration, as seen in collapsing glomerulopathy and in crescentic glomerulonephritis 
(Albaqumi & Barisoni, 2008; Thorner, et al., 2008). Until now, theories explaining the origin 
of aberrant epithelial cells in collapsing glomerulopathy and crescentic glomerulonephritis 
have been controversial. One possibility is that these cells are exclusively of parietal 
epithelial origin (Thorner et al., 2008 ), while another is that some dedifferentiated 
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podocytes acquire markers of parietal epithelial cells (Moeller et al., 2004). It was recently 
demonstrated that the majority of cells present in the hyperplastic lesions in collapsing 
glomerulopathy or crescentic glomerulonephritis exhibits the RSC markers CD133 and 
CD24, with or without coexpression of podocyte markers (Smeets et al., 2009). Therefore, it 
is suggested that the glomerular hyperplastic lesions are generated by RSC of Bowman’s 
capsule at different stages of their differentiation towards mature podocytes. Support for 
this hypothesis came from lineage tracing experiments performed in transgenic mice with 
genetically labeled parietal epithelial cells in a model of inflammatory crescentic 
glomerulonephritis, and of collapsing glomerulopathy (Smeets et al., 2009).  
Finally, a close relationship between the transcriptome of CD133+ tubular progenitors and 
the one derived by papillary renal cell carcinomas was demonstrated (Lindgren et al. 2011). 
Moreover, a  strong CD133 expression was observed in the papillary renal cell carcinomas 
analysed. Thus, these observations raise the provocative hypothesis that papillary renal cell 
carcinomas may directly derive from CD133+CD24+ renal tubular progenitors, whereas clear 
renal cell carcinomas may derive from other more differentiated proximal tubular cells.   
6.2 Signaling pathway regulating the RSC niche 
The molecular mechanisms regulating the proliferation of RSC, as well as the cell fate 
determination in the podocyte lineage are unknown. We recently demonstrate the role of the 
Notch signaling pathway in both these processes (Lasagni et al., 2010). Notch activation 
triggers the expansion of renal progenitors by promoting their entry into the S-phase of the 
cell cycle and mitotic division. Moreover, Notch downregulation is required for 
differentiation toward the podocyte lineage. However, Notch downregulation was neither 
sufficient nor necessary for the acquisition of a podocyte phenotype, but an impaired 
downregulation of the Notch pathway led to podocyte death. Indeed, renal progenitor 
differentiation into podocytes was associated with cell cycle checkpoint activation and 
G2/M arrest, reflecting an intrinsic barrier to replication of mature podocytes. Persistent 
activation of the Notch pathway induced podocytes to cross the G2/M checkpoint, resulting 
in cytoskeleton disruption and cell death (Lasagni et al., 2010). Notch expression was 
virtually absent in the glomeruli of healthy adult kidneys, while a strong upregulation was 
observed in renal progenitors and podocytes in patients affected by glomerular disorders. 
Accordingly, inhibition of the Notch pathway in mouse models of focal segmental 
glomerulosclerosis ameliorated proteinuria and reduced podocyte loss during the initial 
phases of glomerular injury, while inducing reduction of progenitor proliferation during the 
regenerative phases of glomerular injury with worsening of proteinuria and 
glomerulosclerosis. Taken altogether, these results suggest that the severity of glomerular 
disorders depends on the Notch-regulated balance between podocyte death and 
regeneration provided by renal progenitors (Lasagni et al., 2010).  
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